SAN DIEGO, Sept. 11, 2013 /PRNewswire/ -- SynteractHCR, a full-service, global contract research organization (CRO), will host an educational series on "Taking Time and Cost Out of Drug Development," with three Webinars to support its Intelligent Clinical Development (ICD+) platform. Each webinar will be presented by a SynteractHCR expert with biopharma industry panelists and will be free of charge to attendees.
The first webinar, "Selecting the Right Electronic Data Capture (EDC) Platform" will be held on Monday, Sept. 23 from 1 to 2 p.m. EDT. It will include a 50-minute presentation and a 10-minute Q-and-A session at the end of the course. The webinar will be co-presented by Toby Odenheim, MBA, director, clinical technology services at SynteractHCR and Cathi Sciacca, executive director, clinical operations at Intercept Pharmaceuticals, Inc.
The webinar is tailored to managers and executives who are involved with clinical data management and clinical system selection. The session will demonstrate how selecting the right EDC can help ensure project success and return on investment. The speakers will discuss how to evaluate vendors and systems, how to identify functional and user requirements, and how to complete a detailed assessment of the final chosen vendors.
The second webinar will be held in December. The topic will focus on how proactive planning in study start-up drives efficiencies in drug development. The presentation will encompass a broad overview, providing the perspectives of sponsor, industry and CRO. More information on this session will be released online. A third webinar will be announced at a later date.
SynteractHCR recently introduced its ICD+ platform to leverage the company's deep clinical development expertise, appropriate technology, and optimized execution to drive solution-oriented efficiencies and consistent standards on a global scale. The webinar series speaks to elements of this comprehensive methodology and identifies ways to take time and cost out of the drug development process.
About SynteractHCR (www.synteracthcr.com) SynteractHCR is a full-service contract research organization with a successful two-decade track record supporting biotechnology, medical device and pharmaceutical companies in all phases of clinical development. With its "Shared Work – Shared Vision" philosophy SynteractHCR provides customized Phase I through IV services collaboratively and cost effectively ensuring on-time delivery of quality data so clients get to decision points faster. Operating in 16 countries, SynteractHCR delivers trials internationally, offering expertise across multiple therapeutic areas including notable depth in oncology, CNS, infectious disease, endocrinology, cardiovascular and respiratory, among other indications.